Back to search

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

Data up to Jan 2025

Published1996
Citations613
References33

Total Citations Per Year

Abstract

References (33)

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

1992 • 1,063 citations

Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line

1993 • 898 citations

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

1994 • 731 citations

Activation of Programmed Cell Death in the Rat Ventral Prostate after Castration*

1988 • 730 citations

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

1993 • 597 citations

Expression of the prostate-specific membrane antigen.

1994 • 582 citations

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

1995 • 541 citations

The Promoter of the Prostate-Specific Antigen Gene Contains a Functional Androgen Responsive Element

1991 • 452 citations

Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer

1993 • 421 citations

Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids

1995 • 362 citations

Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. IV. Anti-Androgen Treated Patients

1989 • 212 citations

Hormonal regulation of prostate‐specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

1992 • 179 citations

Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone

1983 • 177 citations

The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate Cancer

1992 • 175 citations

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

1994 • 173 citations

Pathologic changes associated with androgen deprivation therapy for prostate cancer

1991 • 161 citations

Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells.

1995 • 154 citations

Radioimmunoscintigraphy with111Indium Labeled Cyt-356 for the Detection of Occult Prostate Cancer Recurrence

1994 • 148 citations

Radioimmunoscintigraphy of Pelvic Lymph Nodes with111Indium-Labeled Monoclonal Antibody CYT-356

1994 • 141 citations

Endocrine Therapy in Carcinoma of the Prostate Gland: 10-Year Survival Studies

1960 • 118 citations

Radiation-induced apoptosis in a murine T-cell hybridoma.

1992 • 116 citations

Immunoscintigraphy of prostatic cancer: Preliminary results with 111in‐labeled monoclonal antibody 7E11‐C5.3 (CYT‐356)

1991 • 95 citations

Prostatic cell lineage markers: Emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration

1996 • 81 citations

Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline.

1993 • 68 citations

Endocrine Therapy for Prostate Cancer

1991 • 64 citations

Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapy

1992 • 58 citations

Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer.

1992 • 53 citations

Prostate Specific Antigen Regression and Progression after Androgen Deprivation for Localized and Metastatic Prostate Cancer

1995 • 53 citations

Chemotherapy for prostatic carcinoma.

1988 • 45 citations

Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy

1985 • 40 citations

Hormonal regulation of transforming growth factor β-2 expression in human prostate cancer

1993 • 35 citations

A pilot trial of chemohormonal therapy for metastatic prostate carcinoma

1992 • 20 citations

Epirubicin plus flutamide and orchidectomy in previously untreated advanced prostatic cancer.

1991 • 15 citations

Cited By (0)

No citing papers found in database

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy (1996) – Urology | Metascience Observatory Explorer